VecPrime: immune priming to vaccinate vectors (360G-Wellcome-212450_Z_18_Z)

£97,301

Mosquito-borne diseases are hugely harmful to people and livestock. Understanding how the mosquito vectors’ immune system resists pathogen infection is crucial to understanding and controlling these infectious diseases. Despite lacking the vertebrate adaptive immune system, insects are able to retain memory of their immunological history through a poorly understood phenomenon known as immune priming. We have developed a method to effectively ‘vaccinate’ mosquitoes against the globally important mosquito-borne West Nile virus (WNV). Here, we propose to expand on our findings to understand the mechanisms and fundamental evolutionary principles behind immune memory in a medically relevant vector system. By using a powerful combination of experimental approaches we will: 1) identify the degree to which mosquito priming varies across mosquito vectored viruses, 2) test whether priming offers cross-protection against other viruses, 3) identify candidate genes responsible for priming using RNAseq, and 4) determine whether cellular responses are necessary for immune priming. Taken together, the results will identify the extent, specificity and mechanisms of priming in mosquitoes and establish a system to explore whether priming could serve as a form of disease control across a wider range of medically and agriculturally important disease vectors.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 97301
Applicant Surname Barribeau
Approval Committee Science Seeds Advisory Panel
Award Date 2018-05-21T00:00:00+00:00
Financial Year 2017/18
Grant Programme: Title Seed Award in Science
Internal ID 212450/Z/18/Z
Lead Applicant Dr Seth Barribeau
Partnership Value 97301
Planned Dates: End Date 2019-12-31T00:00:00+00:00
Planned Dates: Start Date 2018-11-01T00:00:00+00:00
Recipient Org: Country United Kingdom
Region North West